China Kangtai owns nearly 400 acres of farmland and grows three species of Mexican cacti and some of the Company's own cloned species. The Company owns an R & D institute that has successfully produced 31 product patents, 15 of which have already been approved. It currently produces and sells four cactus- based product categories: nutraceuticals, which are health and wellness dietary supplements; beverages, including juice, teas, beer, wine, and spirits; packaged foods, such as noodles, biscuits and pickles; and raw and intermediate cactus materials. There are about 36 existing products under these four categories.
Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, "Cactus-based products are well-received by the market in China and show huge growth potential. China Kangtai will continue to develop new products to meet the demand of the consumers, while penetrating the markets with its existing products."
Wang concluded, "Our Company remains focused on the quality and
functionality of our products that deliver various health benefits to
consumers. These new products will contribute positively to the Company's
2007 performance and beyond, and accelerate its revenue and profit growth.
With 15 product patents and 16 pending approval, China Kangtai is the
|SOURCE China Kangtai Cactus Bio-tech, Inc.|
Copyright©2007 PR Newswire.
All rights reserved